Pharmacokinetics, absolute bioavailability and tolerability of ketamine after intranasal administration to dexmedetomidine sedated dogs.
Intranasal ketamine has recently gained interest in human medicine, not only for its sedative, anaesthetic or analgesic properties, but also in the management of treatment resistant depression, where it has been shown to be an effective, fast acting alternative treatment. Since several similarities...
Main Authors: | Lise Vlerick, Mathias Devreese, Kathelijne Peremans, Robrecht Dockx, Siska Croubels, Luc Duchateau, Ingeborgh Polis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0227762 |
Similar Items
-
Anaesthesia, not number of sessions, influences the magnitude and duration of an aHF-rTMS in dogs.
by: Robrecht Dockx, et al.
Published: (2017-01-01) -
Accurate external localization of the left frontal cortex in dogs by using pointer based frameless neuronavigation
by: Robrecht Dockx, et al.
Published: (2017-07-01) -
Kinetic analysis of [18F] altanserin bolus injection in the canine brain using PET imaging
by: Glenn Pauwelyn, et al.
Published: (2019-11-01) -
Intranasal dexmedetomidine and intranasal ketamine association allows shorter induction time for pediatric sedation compared to intranasal dexmedetomidine and oral midazolam
by: Francesca Cossovel, et al.
Published: (2022-01-01) -
PET quantification of [18F]MPPF in the canine brain using blood input and reference tissue modelling.
by: Glenn Pauwelyn, et al.
Published: (2019-01-01)